Orbimed Advisors LLC, 10% Owner at Passage BIO, Inc. (PASG), sold 235,572 shares at $0.32 ($79K) on 2025-04-24, disclosed to the SEC on 2025-04-24.
Open-market sale of $79k PASG by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.34 | 78,049 | $27K | 33.7% |
| 2 | $0.34 | 89,328 | $30K | 38.6% |
| 3 | $0.32 | 68,195 | $22K | 27.7% |
| Total | $0.33 avg | 235,572 | $79K | 100% |
| Filing → |
| BRVE | BUY | 2026-08-11 | $34.9M | — | Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| SION | SELL | 2026-07-09 | $3.9M | — | Filing → |